- Home
- TWST vs NOVTU Comparison
TWST vs NOVTU Comparison
Compare TWST & NOVTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TWST | NOVTU |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TWST | NOVTU |
|---|---|---|
| Price | $35.16 | $54.79 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $44.88 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | N/A |
| Earning Date | 02-02-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $376,572,000.00 | N/A |
| Revenue This Year | $15.19 | N/A |
| Revenue Next Year | $15.10 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 20.32 | N/A |
| 52 Week Low | $23.30 | N/A |
| 52 Week High | $55.33 | N/A |
Technical Indicators
Market Signals| Indicator | TWST | NOVTU |
|---|---|---|
| Relative Strength Index (RSI) | 65.30 | N/A |
| Support Level | $30.21 | N/A |
| Resistance Level | $33.75 | N/A |
| Average True Range (ATR) | 1.89 | 0.00 |
| MACD | 0.28 | 0.00 |
| Stochastic Oscillator | 97.56 | 0.00 |
Price Performance
Historical ComparisonAbout TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.